This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Companies in this article
Catalent Pharma Solutions, the world's leading provider of advanced oral drug delivery technologies and solutions, announced that it has entered into a license agreement with Pantec AG for the exclusive worldwide development rights to the Lyopan fast-dissolve technology for healthcare products.
This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.